Higa E M, Schor N, Boim M A, Ajzen H, Ramos O L
Braz J Med Biol Res. 1985;18(3):355-65.
The role of humoral factors in the pathogenesis of gentamicin and tobramycin aminoglycoside-induced acute renal failure was studied in rats. Renal function was evaluated after inhibition of prostaglandin synthesis with indomethacin and inhibition of the kallikrein-kinin system with aprotinin. Plasma and urinary kallikrein levels were measured in aminoglycoside-treated rats, as was in vitro effect of of these antibiotics on plasma kallikrein activity and prekallikrein activation by dextran sulfate. Indomethacin treatment (2 mg kg-1 day-1, ip, for 13 days) of rats which received gentamicin or tobramycin (40 mg kg-1 day-1, ip, for 10 days) caused a further fall in glomerular filtration rate (GFR) and renal blood flow and an impressive increase in renal resistance. The effect of indomethacin on GFR was more evident for gentamicin- than tobramycin-treated animals. Aprotinin administration had no additional effects on the renal function of antibiotic-treated rats. Plasma and urinary kallikrein levels in aminoglycoside-treated rats were significantly lower than in untreated controls. Both aminoglycosides at concentrations of 0.1 mg/ml inhibited dextran sulfate activation of plasma prekallikrein, and 2.0 micrograms/ml tobramycin, but not gentamicin, inhibited the hydrolysis of H-D-Pro-Phe-Arg-p-nitroanilide by rat plasma. These data suggest that prostaglandins may protect against aminoglycoside nephrotoxicity.
在大鼠中研究了体液因子在庆大霉素和妥布霉素氨基糖苷类诱导的急性肾衰竭发病机制中的作用。在用吲哚美辛抑制前列腺素合成以及用抑肽酶抑制激肽释放酶-激肽系统后,评估肾功能。测定了氨基糖苷类处理大鼠的血浆和尿液激肽释放酶水平,以及这些抗生素对血浆激肽释放酶活性和硫酸葡聚糖激活前激肽释放酶的体外作用。对接受庆大霉素或妥布霉素(40mg/kg体重,腹腔注射,共10天)的大鼠进行吲哚美辛处理(2mg/kg体重,腹腔注射,共13天),导致肾小球滤过率(GFR)和肾血流量进一步下降,肾阻力显著增加。吲哚美辛对GFR的影响在庆大霉素处理的动物中比在妥布霉素处理的动物中更明显。给予抑肽酶对接受抗生素处理大鼠的肾功能没有额外影响。氨基糖苷类处理大鼠的血浆和尿液激肽释放酶水平显著低于未处理的对照组。两种氨基糖苷类药物在浓度为0.1mg/ml时均抑制血浆前激肽释放酶的硫酸葡聚糖激活,而2.0μg/ml的妥布霉素(但不是庆大霉素)抑制大鼠血浆对H-D-脯氨酸-苯丙氨酸-精氨酸-对硝基苯胺的水解。这些数据表明前列腺素可能对氨基糖苷类肾毒性具有保护作用。